Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + Paclitaxel for Unresectable Gastric Cancer
NCT01756183Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, Paclitaxel Micelles for Injection in gastric cancer (GC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
tegafurPaclitaxel Micelles for Injection
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01756183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756183.